Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis

• Egile Nagusiak: Maria Chiara Gerardi (Egilea), Francesca Crisafulli (Egilea), Antía García-Fernandez (Egilea), Daniele Lini (Egilea), Chiara Bazzani (Egilea), Ilaria Cavazzana (Egilea), Matteo Filippini (Egilea), Micaela Fredi (Egilea), Roberto Gorla (Egilea), Maria Grazia Lazzaroni (Egilea), Cecilia Nalli (Egilea), Marco Taglietti (Egilea), Andrea Lojacono (Egilea), Francesca Ramazzotto (Egilea), Cristina Zanardini (Egilea), Sonia Zatti (Egilea), Franco Franceschini (Egilea), Angela Tincani (Egilea), Laura Andreoli (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objectives: Women with Rheumatoid Arthritis (RA) can experience flares during pregnancy that might influence pregnancy outcomes. We aimed at assessing the disease course during pregnancy and identifying risk factors for flares.Methods: Data about prospectively-followed pregnancies in RA were retrosp...